Po-sertraline (2017-01-13)

Apo-Sertraline Recall Summary Apo-Sertraline, an antidepressant medication, has been recalled across Canada due to a product safety issue. The recall is classified as Class I, meaning there is a serious potential health risk. This recall affects all Canadian consumers who have this medication.

Reason

Product safety

Classification

Class I

Category

drug recall

Country

Canada

Agency

HC-DRUGS

Recall date

2017-01-16

Status

Closed

Distribution

Canada-wide

Official recall notice from HC-DRUGS

Recall details on Nibble Recalls: https://trynibble.app/recalls/1dfb0fce-a64e-4638-bf1e-3d507cbf0712